Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Compared with those without ILD, RA-ILD patients were older, had longer disease duration, higher disease activity, elevated C-reactive protein/erythrocyte sedimentation rate, lower 25-hydroxyvitamin D, higher bone alkaline phosphatase levels, and greater cumulative glucocorticoid exposure (all P < .05).
Source: Abstract. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Cohort study.
Cohort study
Examines exposures and outcomes over time within a defined group.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
This single-center retrospective cohort study included 150 patients with confirmed RA who were admitted to the Department of Rheumatology and Immunology between January 2021 and December 2024 and completed all relevant examinations.
Source: Methods.
Based on high-resolution chest computed tomography (HRCT) findings, patients were categorized into RA-ILD (n = 62, 41.3%) and RA-non-ILD (n = 88, 58.7%) groups.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Association between the severity of interstitial lung disease and the risk of osteoporotic vertebral fractures in patients with rheumatoid arthritis
Cohort study · Medicine · 2026
Original publication title
Association between the severity of interstitial lung disease and the risk of osteoporotic vertebral fractures in patients with rheumatoid arthritis
Copyright © 2026 the Author(s). Published by Wolters Kluwer Health, Inc.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
What does the authors’ abstract report?
This study aimed to investigate the relationship between interstitial lung disease (ILD) severity and bone mineral density (BMD) and osteoporotic vertebral fractures (OVFs) in patients with rheumatoid arthritis (RA) and determine whether ILD independently affects skeletal health. This retrospective cross-sectional study included 150 RA patients treated between January 2021 and December 2024. Based on high-resolution chest computed tomography, patients were classified as RA-ILD (n = 62) or RA without ILD (n = 88). RA-ILD cases were further stratified by fibrosis extent into mild (<20%, n = 27), moderate (20%: 50%, n = 24), and severe (>50%, n = 11).
Demographic data, clinical features, inflammatory markers, vitamin D, bone turnover indices, and medication exposure, including cumulative glucocorticoid dose, were collected. BMD at the lumbar spine, total hip, and femoral neck was measured by dual-energy X-ray absorptiometry. OVF was assessed by thoracolumbar radiography or computed tomography using the Genant semiquantitative method. Group comparisons, trend analyses, correlation analyses, and multivariable logistic regression were performed to identify independent risk factors for OVF. ILD was present in 41.3% of RA patients. Compared with those without ILD, RA-ILD patients were older, had longer disease duration, higher disease activity, elevated C-reactive protein/erythrocyte sedimentation rate, lower 25-hydroxyvitamin D, higher bone alkaline phosphatase levels, and greater cumulative glucocorticoid exposure (all P < .05).
Lumbar spine, total hip, and femoral neck BMD were significantly lower in the RA-ILD group, accompanied by a lower lumbar T-score. OVF prevalence was higher in RA-ILD patients (30.6% vs 14.8%), including more multiple fractures. Within the RA-ILD cohort, BMD declined progressively with increasing ILD severity, and pulmonary function indices (forced vital capacity [%] and diffusing capacity for carbon monoxide [%]) showed positive correlations with BMD. OVF frequency rose stepwise from mild to severe ILD (14.8%, 29.2%, and 54.5%). Multivariable analysis identified ILD severity as an independent predictor of OVF (odds ratios = 2.51, 95% confidence interval: 1.21 to 5.22), together with age and cumulative glucocorticoid exposure.
RA patients with ILD exhibit significantly reduced BMD and an increased risk of OVFs, which worsen with ILD severity. ILD appears to be an independent risk factor for skeletal deterioration in RA, highlighting the importance of early bone health assessment and preventive management in this population.
Authors’ abstract
This study aimed to investigate the relationship between interstitial lung disease (ILD) severity and bone mineral density (BMD) and osteoporotic vertebral fractures (OVFs) in patients with rheumatoid arthritis (RA) and determine whether ILD independently affects skeletal health. This retrospective cross-sectional study included 150 RA patients treated between January 2021 and December 2024. Based on high-resolution chest computed tomography, patients were classified as RA-ILD (n = 62) or RA without ILD (n = 88). RA-ILD cases were further stratified by fibrosis extent into mild (<20%, n = 27), moderate (20%: 50%, n = 24), and severe (>50%, n = 11).
Demographic data, clinical features, inflammatory markers, vitamin D, bone turnover indices, and medication exposure, including cumulative glucocorticoid dose, were collected. BMD at the lumbar spine, total hip, and femoral neck was measured by dual-energy X-ray absorptiometry. OVF was assessed by thoracolumbar radiography or computed tomography using the Genant semiquantitative method. Group comparisons, trend analyses, correlation analyses, and multivariable logistic regression were performed to identify independent risk factors for OVF. ILD was present in 41.3% of RA patients. Compared with those without ILD, RA-ILD patients were older, had longer disease duration, higher disease activity, elevated C-reactive protein/erythrocyte sedimentation rate, lower 25-hydroxyvitamin D, higher bone alkaline phosphatase levels, and greater cumulative glucocorticoid exposure (all P < .05).
Lumbar spine, total hip, and femoral neck BMD were significantly lower in the RA-ILD group, accompanied by a lower lumbar T-score. OVF prevalence was higher in RA-ILD patients (30.6% vs 14.8%), including more multiple fractures. Within the RA-ILD cohort, BMD declined progressively with increasing ILD severity, and pulmonary function indices (forced vital capacity [%] and diffusing capacity for carbon monoxide [%]) showed positive correlations with BMD. OVF frequency rose stepwise from mild to severe ILD (14.8%, 29.2%, and 54.5%). Multivariable analysis identified ILD severity as an independent predictor of OVF (odds ratios = 2.51, 95% confidence interval: 1.21 to 5.22), together with age and cumulative glucocorticoid exposure.
RA patients with ILD exhibit significantly reduced BMD and an increased risk of OVFs, which worsen with ILD severity. ILD appears to be an independent risk factor for skeletal deterioration in RA, highlighting the importance of early bone health assessment and preventive management in this population.
Publication and source details
Original title: Association between the severity of interstitial lung disease and the risk of osteoporotic vertebral fractures in patients with rheumatoid arthritis
Na Li; Jiaxin Li
Medicine · 2026
* Correspondence: Jiaxin Li, Department of Rheumatology and Immunology, Xuzhou Central Hospital, Xuzhou City 221000, Jiangsu Province, China (e-mail: li57987@163.com).Copyright © 2026 the Author(s). Published by Wolters Kluwer Health, Inc.2026https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T23:51:46.619411+00:00
DOI: 10.1097/md.0000000000048032 · PMC13034962